Circulating hormones and local biotransformation of steroid precursors are both sources of estrogen in human mammary tissue. Estrone-3-sulfate (E 1 S) is an important estrogenic form in premenopausal women, and dehydroepiandrosterone sulfate (DHEAS) constitutes a major adrenal precursor. Membrane transport systems that govern delivery of these anionic steroid conjugates to the mammary gland were investigated. 
T HE MAMMARY GLAND is an estrogen-responsive tis-
sue. Estrogens act through the estrogen receptors to direct normal lobular development, regulate epithelial cell growth, and increase the expression of steroid hormone metabolizing enzymes (1, 2) . Moreover, estrogen is the most important etiological factor that supports the growth of estrogen receptor-positive breast tumors. One source of estrogen is local biosynthesis within the epithelial cells and stromal fibroblasts from the adrenally derived precursors, dehydroepiandrostenedione (DHEA) and androstenedione. DHEA circulates primarily in its 3␤-sulfate form, dehydroepiandrosterone sulfate (DHEAS), and serves as the principal conjugated prohormone for the biosynthesis of both estrogenic [17␤-estradiol (E 2 ), estrone (E 1 ), and 5-androstenediol] and androgenic (testosterone) steroids in peripheral tissues (3, 4) . The enzymes that catalyze the desulfation of DHEAS, the subsequent 3␤ oxidation of DHEA to androstenedione and 17␤ reduction of androstenedione to testosterone, as well as the aromatization of testosterone and androstenedione into E 2 and E 1 , respectively, have all been detected in breast tissue and studied in breast cancer cell lines (5) (6) (7) . A second source of estrogen are the circulating hormones, the composition and concentration of which vary widely as a function of age. In premenopausal women, estrone 3-sulfate (E 1 S) is the major form, and its cyclical concentrations range from 2.5 to 15 nmol/liter (8, 9) . In breast tissue, E 1 S is sequentially desulfated and reduced to the more potent E 2 (7, 10) . In postmenopausal women, the estrogen concentrations decline, although adrenally derived DHEAS levels can remain above 2-3 mol/liter even into the seventh decade (11) .
The activities of several key enzymes necessary for in situ estrogen production are higher in tumors compared with normal tissue (12, 13) , in keeping with the widely held tenet that sex steroid exposure is a strong risk factor for breast cancer. There are also epidemiological data to support an association between the circulating concentrations of hormones and prohormones, including E 1 S and DHEAS, and the eventual risk of developing breast cancer, especially in the postmenopausal years (14, 15) . This link implies that steroids in their sulfated, anionic form gain access to the intracellular milieu and can determine the extent of exposure to downstream, biologically active hormones. Sulfated steroid conjugates carry a net negative charge at physiological pH levels, and as such, their transfer across cell membranes is carrier mediated. Steroid sulfates have been identified as substrates for distinct members of two organic anion carrier gene families: the organic anion transporting polypeptide (OATP) superfamily, classified within the solute carrier 21A gene family (SLC21A) (16) and the organic anion transporter (OAT) family, encoded by the solute carrier 22A (SLC22A) genes (17) . OATPs are multispecific transporters expressed in many tissues, including the liver, brain, and placenta, where they mediate the Na ϩ -independent uptake of a host of organic anionic compounds. In particular, OATP-A (SLC21A3) (18) , OATP-B (SLC21A9) (19) , the liver-specific OATP-C (SLC21A6) and OATP-8 (SLC21A8) (20, 21) , OATP-E (SLC21A12) (22) , and OATP-F (SLC21A14) (23) have all shown convincingly that they accept selected conjugated steroids as substrates. Four isoforms of the OAT carrier family have been characterized. Of these, OAT3 (SLC22A8) and OAT4 (SLC22A11) mediate the cellular uptake of certain steroid conjugates in the kidney, liver, brain, and placenta (24 -26) .
Because the transport processes operative in mammary tissue will govern the cellular entry of conjugated steroids, it follows that individual carrier proteins may, in part, be determinants of downstream estrogen exposure in target cells. Accordingly, the identification and characterization of the relevant transporters present in human mammary epithelia deserve a detailed investigation. The aim of this study was to identify and characterize the organic anion uptake systems for conjugated steroids. Our findings show that OATP-B (SLC21A9) may be the most functionally relevant steroid sulfate carrier present and is able to account for delivery of both E 1 S and DHEAS to normal and tumor breast tissue. [6, [5,6- 3 H]-PGE 1 and purified by thin-layer chromatography, as described by Andersen (27) . All cell culture media and reagents were obtained from Life Technologies (Paisley, UK) or Sigma-Aldrich Chemie (Steinheim, Germany). Steroids used in inhibition studies were obtained from Steraloids (Newport, RI); prostaglandin (PG) A 1 and A 2 were purchased from Alexis Corporation (Lausen, Switzerland); and unlabeled PGE, 2-cyclopenten-1-one, and N-ethylmaleimide (NEM) were purchased from Sigma-Aldrich Chemie (Steinheim, Germany). Acetamido-4Ј-(iodoacetyl)amino-stilbene-2,2Ј-disulfonic (IASD) acid was purchased from Molecular Probes (Eugene, OR). All other chemicals and reagents were of analytical grade and are available from commercial sources.
Materials and Methods Materials

RT-PCR
Expression of the known members of the OATP and OAT gene superfamilies in normal human mammary tissue was studied by RT-PCR assay. Reverse transcription was performed using total RNA (Clontech, Palo Alto, CA) primed with Oligo(dT) 15 as a template and AMV Reverse Transcriptase (Promega, Wallisellen, Switzerland). PCR amplification used primers specific for each transporter (Table 1 ) and the following conditions: one cycle of 95 C for 2 min; 40 cycles of 95 C for 45 sec; primer-specific annealing temperature for 45 sec; 72 C for 1 min; and a final elongation of 72 C for 5 min. The primer-specific annealing temperature was 50 C for OATP-A, OATP-C, OATP-D, OATP-E, OATP-F, and OATP8, 58 C for hPGT, 63 C for OATP-B, and 55 C for all OATs.
Northern blot analysis
Twenty micrograms of normal human mammary gland total RNA (Clontech) per lane were loaded on a 1% agarose-formaldehyde gel. After electrophoresis, the gel was washed three times for 10 min in 10ϫ saline sodium citrate (SSC) and transferred overnight in 20ϫ SSC to a Hybond-NX (Amersham Biosciences) nylon membrane. The blot was prehybridized for 30 min at 68 C in ULTRAhyb (Ambion, Austin, TX) and hybridized overnight at 68 C in the same buffer with a 32 P-labeled antisense-RNA probe (nucleotides of the published sequences: OATP-A nts 1959 -2614, accession no. NM_134431; OATP-B nts 266 -984, accession no. NM_007256; OATP-D nts 1742-1905, accession no. NM_013272; OATP-E nts 1251-1551, accession no. NM_016354; OATP-F nts 1-545, accession no. AF260704, with a specific activity of 1.4 counts per minute ϫ 10 6 /ml. The blots were washed twice for 5 min with 2ϫ SSC/0.1% SDS at 68 C, twice for 15 min with 0.1ϫ SSC/0.1% SDS at 68 C, and then exposed to autoradiography film at Ϫ70 C with an intensifying screen, for 2 d for OATP-B and 5 d for OATP-A, OATP-D, OATP-E, and OATP-F.
Immunohistochemistry
Breast tissue was obtained from routine biopsies evaluated by the pathology department, sectioned at 10 m on a cryostat, fixed for 5 sec in acetone at room temperature, air dried, and stored at Ϫ80 C. Sections were postfixed for 12 min in 4% paraformaldehyde in PBS (pH 7.4) and washed three times in PBS. Nonspecific binding was blocked for 30 min with 10% normal goat serum/0.05% Triton in Tris-buffered saline. The sections were incubated for 1.5 h at room temperature with an affinitypurified OATP-B rabbit antiserum (28) , diluted to an IgG concentration of 70 g/ml in ChemMate diluent (DAKO, Glostrup, Denmark) with 0.05% Triton. Control experiments were performed by incubating sections with normal rabbit IgG and by preadsorption of the antiserum with 20 g/ml of the antigenic peptide. Sections were washed three times with PBS, incubated for 30 min at room temperature with a Cy2-conjugated F(abЈ) 2 fragment goat antirabbit IgG (Jackson ImmunoResearch, West Grove, PA), diluted to 3 g/ml in DAKO ChemMate diluent, then washed (three times) in PBS. Finally, sections were incubated for 2 min in 5 mm 4Ј-6-diamidino-2-phenylindole (DAPI), washed with PBS, briefly rinsed with water, then mounted with fluorescent 
RT-PCR was performed using total RNA from normal mammary gland as a template. Primers and PCR conditions specific for each transporter are described in Materials and Methods. (ϩ), Transcript present; (Ϫ), no transcript detectable. mounting medium (DAKO) and examined by confocal laser scanning microscopy (Leica, Wetzlar, Germany). For double-labeled immunofluorescence, one of the following primary antibodies was included: mouse monoclonal antihuman cytokeratin AE1/AE3 (DAKO), 1.74 g/ml; mouse monoclonal antihuman calponin Ab-1, clone CALP (NeoMarkers, Fremont, CA), 2 g/ml; or mouse monoclonal antihuman Ki-67 antigen, clone MIB-1 (DAKO), 700 g/ml. The Alexa Fluor 647-conjugated F(abЈ) 2 fragment of goat antimouse IgG (Molecular Probes, Eugene, OR), 2.5 g/ml, served as the secondary antibody.
Stable transfection of OATP-B in CHO-K1 cells
Chinese hamster ovary (CHO)-K1 cells were cultured in DMEM (Life Technologies) supplemented with 10% fetal calf serum, 2 mmol/liter l-glutamine, 50 g/ml l-proline, 100 U/ml penicillin, and 100 g/ml streptomycin at 37 C with 5% CO 2 and 95% humidity. Selective medium contained 500 g/ml G418 sulfate (Life Technologies). The OATP-B open reading frame, originally cloned from human brain (19) , was directionally subcloned into the pIRESneo2 (Clontech) expression vector and transfected into CHO-K1 wild-type cells by electroporation as follows: subconfluent CHO-K1 cells were trypsinized and resuspended in cell culture medium. Approximatively 10 7 cells were transferred to a 0.4-cm Gene Pulser cuvette (Bio-Rad, Hercules, CA), mixed with 20 g plasmid and incubated for 10 min on ice before electroporation using a single electrical pulse with an initial field strength of 250 V, discharged from the 960-F capacitor (Bio-Rad). After a 10-min incubation on ice, the cells were plated on 10-cm culture dishes, then selected in G418 (1000 g/ml). Single clones were isolated from the transfected cell pool using cloning cylinders and tested for sodium-independent E 1 S uptake. The clone with the highest transport activity was selected.
For immunofluorescent detection of OATP-B in stably transfected CHO-K1 cells grown on glass coverslips, sodium butyrate (5 mmol/ liter) was added to the culture medium for 24 h. Cells were fixed in 4% paraformaldehyde for 1 h, permeabilized for 10 min with saponin (0.1%) in PBS, and blocked with gelatin (2%) and BSA (1%) in PBS containing 0.1% saponin for 40 min, then incubated with OATP-B antiserum, diluted to 6 g IgG per milliliter in PBS with 0.1% saponin and 1% BSA. The Cy2-conjugated F(abЈ) 2 fragment goat antirabbit secondary antibody was diluted in PBS with 1% BSA.
Transport assays
The uptake of radiolabeled substrates in OATP-B transfected CHO cells was measured in triplicate, as follows: cells were grown to confluency on 35-mm dishes and stimulated for 24 h with 5 mmol/liter sodium butyrate (29) . Individual dishes were rinsed three times with prewarmed (37 C) uptake buffer consisting of 116 mmol/liter NaCl, 5. 
Real time quantitative PCR
Total RNA was extracted from the breast cancer cell line T-47D (American Type Culture Collection, Manassas, VA), CHO-K1 wild-type cells, and OATP-B stable transfected CHO cells using the TRIzol Reagent (Life Technologies). Additional RNA from the breast cell lines MCF-7 and MDA-MB-453 and the hepatocyte cell line Hep-G2 was purchased from Ambion, Inc. (Austin, TX). Reverse transcription of 2 g total RNA was performed with random hexamer primers and 125 U reverse transcriptase (MultiScribe, Applied Biosystems, Rotkreuz, Switzerland). An aliquot (50 ng) was used as a template for real-time PCR (TaqMan, ABI PRISM 7700 Sequence Detector, Applied Biosystems). Primers and the VIC dye-labeled probe for 18S ribosomal RNA, which served as the internal control, were provided by Applied Biosystem. The primers and probe that detected OATP-B have been characterized previously (28) : forward primer 5Ј-AGGACGTGCGGCCAAGT-3Ј, reverse primer 5Ј-TCTTTAGGTAGCCGGAGATCATG-3Ј, FAM/TAMRA-labeled probe 5Ј-CATCAAGCTGTTCGTTCTGTGCCACA-3Ј. To detect OATP-D, the following were designed: forward primer 5Ј-GGTGTCCACTGCTTGC-TACGT-3Ј, reverse primer 5Ј-TCGGTTTGGCATTCACAGTTATT-3Ј, FAM/TAMRA-labeled probe 5Ј-AACAGCACAGCACCTGGCTCA-GCC-3Ј. To detect OATP-E, the following were designed: forward primer 5Ј-GCGAGCAACCCGGACTT-3Ј, reverse primer ACATGCCG-GTGATGAGAGTG-3Ј, FAM/TAMRA-labeled probe 5Ј-AGACCTGC-CTCTCTCCATCTGGCTCC-3Ј.
Results
Detection of OATs in human mammary gland by RT-PCR and Northern blot analysis
RT-PCR of total RNA from normal mammary gland detected transcripts for the following carriers: OATP-A, OATP-B, OATP-D, OATP-E, and OATP-F. The liver-specific carriers, OATP-C and OATP-8, and the related PG transporter (SLC21A2) were not present, nor was expression of transporters belonging to the OAT family detected (Table 1) . Subsequent Northern blot analyses ( Fig. 1) confirmed the presence of OATP-B, which showed a major hybridization signal at 4 kb and a minor band at 1.7 kb after 2 d of exposure. OATP-D and OATP-E showed weaker signals at 3.8 kb and 3.3 kb, respectively, but required exposure for 5 d. Signals for OATP-A and OATP-F could not be detected by Northern blotting, suggesting a very low abundance.
Immunofluorescent localization of OATP-B in the mammary gland
Because of the apparent abundance at the RNA level relative to the other carriers tested, OATP-B was chosen for further characterization. OATP-B was immunolocalized in frozen sections from biopsy material. In tissue with normal appearance, cut from the edges of tumor regions, the OATP-B immunolabeling was weak and discontinuous, and confined to the membranes of the external cell layer that surround the ductules ( Fig. 2A) . Control sections incubated with the preadsorbed OATP-B antibody were negative (Fig.  2B) . Normal ductal epithelial cells did not show a signal.
Morphologically, the cells displaying the positive OATP-B signal were characteristic of the contractile myoepithelial cells that line the ducts of the mammary gland. Double labeling with an antibody to calponin, a smooth muscle cellspecific protein that is a differentiation marker for myoepithelial cells of the breast (30) , confirmed the colocalization of calponin and OATP-B to the same cell type (Fig. 2, C-E) . In tumor-bearing tissue, OATP-B was most apparent in areas of invasive ductal carcinoma, where it was localized to the membrane of cytokeratin-positive epithelial cells (Fig. 2, F and G) but lost its association with myoepithelial cells (Fig.  2H) . OATP-B also retained its membrane expression in neoplastic cells that displayed a positive reaction to the Ki-67 antigen, an indicator of cells in an active proliferating state (Fig. 2I ).
Immunolocalization and transport activity of recombinant OATP-B in transfectants
To confirm the membrane expression of OATP-B in stably transfected CHO cells, we immunolocalized the protein after induction of transcription with sodium butyrate. The uniform, positive surface staining indicated marked expression at the plasma membrane (Fig. 3) . Wild-type cells were negative (data not shown).
OATP-B mediates E 1 S uptake when expressed in oocytes (19) and in HEK293 cells (31) with affinity constant (K m ) values estimated to be 4 -6 mol/liter. However, the assignment of DHEAS as a substrate is equivocal, and the extent of its interaction with other steroids has not been investigated. The validity of the OATP-B stably transfected CHO expression system was first tested for E 1 S. Uptake was linear for 20 sec (Fig. 4A) and saturable with an apparent K m value of 5 mol/liter and a maximum velocity (V max ) value of 777 pmol/mg protein⅐min (Fig. 4B) . In cis-inhibition studies with 5 mol/liter [ 3 H]-E 1 S, DHEAS showed a dose-dependent effect that reached statistical significance at 50 mol/liter (Fig. 5A) . Another adrenally derived steroid hormone precursor, pregnenolone sulfate, was a more potent inhibitor and significantly inhibited E 1 S uptake to 50% and 20% of control values at 10 mol/liter and 50 mol/liter, respectively. Other pregnenolone derivatives, 17-OH pregnenolone sulfate and 21-OH pregnenolone sulfate, inhibited uptake to a moderate degree at the higher concentration tested (Fig.  5B) . The unconjugated forms of pregnenolone, 17-OH pregnenolone and 21-OH pregnenolone, exerted no effect when tested at 10 mol/liter (data not shown).
The inhibition by DHEAS and earlier findings that OATP-B-injected oocytes displayed a 1.6-fold signal over control oocytes (19) imply that DHEAS is a weak substrate for this carrier. Because of the importance of DHEAS as an estrogen precursor, the uptake of [ 3 H]-DHEAS was reevaluated in the OATP-B expressing CHO cells. A significant uptake rate was measurable and showed linearity for 40 sec (Fig. 6A) . Nevertheless, the OATP-B-specific signal was weak and displayed large variations when the difference (uptake OATP-B Ϫ uptake wild-type ) was calculated (Fig. 6B) . To confirm that DHEAS uptake in OATP-B-transfected CHO cells was carrier-mediated over a broad concentration range, equation 1, describing saturable Michaelis-Menten kinetics with a non- saturable first-order process, and equation 2, which describes simple nonsaturable first-order kinetics, were curve-fitted to the data.
where is the initial rate of uptake (pmol/min⅐mg), [S] is the substrate concentration (mol/liter), and P represents a firstorder clearance term (l/min⅐mg). The background signal in wild-type CHO cells was well described by equation 2. Total DHEAS uptake in OATP-B transfectants was best described by a saturable component plus a first-order process (equation 1) (Fig. 6B) . The statistical improvement of the curve fit of equation 1 over equation 2 was assessed by the F test (F Ͻ 0.01). The estimated K m and V max values calculated in this way were 9 mol/liter and 85 pmol/min⅐mg, respectively, consistent with the fact that OATP-B has moderate affinity but low capacity for DHEAS. Conversely, no OATP-Bmediated uptake of [ 3 H]-pregnenolone sulfate could be identified (data not shown), despite the strong inhibition of E 1 S transport by this steroid (Fig. 5) .
The interaction of OATP-B and PG
Additional physiological substrates of OATP-B could influence the extent of steroid sulfate uptake in mammary tissue. OATP-B shares 76% identity with the PG transporter (SLC21A2), and other more distantly related members of the solute carrier family 21A, such as OATP-C, do transport PG (21). PGE 2 is especially relevant as a potential substrate for OATP-B because high intratumoral levels are achieved via the cyclooxygenase pathway that is up-regulated in tumors relative to the surrounding normal tissue (32) . The role of OATP-B in PG transport was reevaluated in the stable-transfected CHO cells. Neither PGE 1 nor PGE 2 inhibited [ 3 H]-E 1 S uptake (Fig. 7A) . Additional experiments with radiolabeled PGE 1 and PGE 2 confirmed that OATP-B did not mediate the uptake of PG (data not shown). Unexpectedly, the naturally occurring cyclopentenone PGA 1 , which is derived from PGE 1 , increased OATP-B-mediated [ 3 H]-E 1 S transport (Fig.  7A) . The PGA 1 -mediated stimulation was detectable after 15 sec and was maximal at 1 min (Fig. 7B) . No further stimulation occurred when transport was measured at longer intervals or when cells were preincubated with PGA 1 (data not shown). A more marked stimulation was observed at lower substrate concentrations (500 nmol/liter) with both 100 nmol/liter and 1 mol/liter (Fig. 7B) . PGA 2 , a second cyclopentenone prostanoid derived from PGE 2 , also enhanced E 1 S uptake at similar concentrations. However, PGJ 2 , a third cyclopentenone PG, which differs from the PG of the A series by the position of the reactive electrophilic carbon, had no effect (Fig. 7C) . The PGA 1 and PGA 2 stimulation of transport was also manifest with DHEAS and to the same extent (an increase of 100% Ϯ 5 and 100% Ϯ 10 for PGA 1 and PGA 2 , respectively) (Fig. 7D) .
To further characterize the PGA-stimulated steroid sulfate transport, the estimation of kinetic parameters was repeated in the presence of 1 mol/liter PGA 1 . There was no difference in the K m value for either substrate, but the V max increased by 2-fold for DHEAS (from 85 Ϯ 20 to 166 Ϯ 19 pmol/min⅐mg) and 1.5-fold for E 1 S (from 777 Ϯ 45 to 1191 Ϯ 36 pmol/min⅐mg). To determine whether PGA was a substrate for OATP-B and able to effect stimulation of transport from the trans-side of the cell, we measured the time-dependent uptake of [ 3 H]-PGA 1 . No OATP-B-mediated uptake of PGA 1 occurred (Fig. 8A) . However, a significant signal was evident with both the OATP-B transfectants and wild-type cells, which could represent an element of membrane binding of the radiolabel. The stimulation by PGA 1 and PGA 2 and not PGE 1 and PGE 2 suggests that the cyclopentenone moiety of the compound with its ␣,␤-unsaturated carbonyl group (Fig. 9) , is a key determinant of this activity. Accordingly, cyclopentenone (2-cyclopenten-1-one) itself should mimic the effect of PGA. To test this, E 1 S uptake was measured in the presence of 50 mol/liter and 100 mol/liter cyclopentenone, which resulted in a 1.3-fold and 1.5-fold increase, respectively, in the signal (Fig. 8B) . This suggests that the mechanistic basis for the PGA stimulation is the chemical reactivity of the cyclopentenone ring. In particular, the electrophilic C 11 of PGA 1 and PGA 2 (Fig. 9) is susceptible to addition reactions with nucleophiles such as the free sulfhydryl group of cysteine residues (33) . To investigate whether Cys residues in the OATP-B protein may be target sites for the actions of PGA 1 and PGA 2 , transport studies were performed in the presence of thiol reagents. Cells pretreated with 100 mol/ liter of the membrane-permeable NEM showed a 40% decrease in E 1 S uptake, suggesting that one or more Cys residues are involved in substrate binding and/or transport (Fig. 8C) . In NEM-pretreated cells, the PGA 1 stimulation was completely abrogated. This supports the notion that an interaction with cysteine residues regulates the actions of PGA 1 . Additional experiments with the membrane impermeable, polar sulfhydryl reagent IASD at 500 mol/liter, which accesses only those Cys residues within a hydrophilic environment, supported this view. E 1 S uptake was equally sensitive to the presence of IASD as with NEM (Fig. 8C) . However, a 2-fold stimulation with PGA 1 was still possible, in keeping with the hypothesis that the Cys residues reacting with PGA are inaccessible to the hydrophilic IASD but are nevertheless blocked by NEM.
The presence of OATPs in breast cancer cell lines
To establish whether widely used breast cancer cell lines expressed OATP carriers and could serve as in vitro models for additional studies of steroid sulfate transport, the mRNA expression of OATP-B, OATP-D, and OATP-E was measured in MCF-7, T47D, and MDA-MB-453 cell lines. For comparison, the expression levels in the OATP-B stably transfected CHO cells as well as in the Hep-G2 cell line, which reportedly expresses both OATP-B and OATP-E (34), are given. None of the breast cancer lines examined gave detectable signals for OATP-B above background levels (Table 2) . Conversely, when standardized for expression in Hep-G2 cells, our studies identified MCF-7 as the cell line with the highest expression of OATP-E (13-fold higher than Hep-G2), whereas the MDA-MB-453 and T47-D cell lines express 10-fold and 100-fold less, respectively. Although no standard cell line was after 1 min at 37 C. Cyclopentenone at 50 mol/liter and 100 mol/ liter significantly stimulated transport compared with control conditions (no cyclopentenone). C, The effect of thiol reagents on PGA stimulation of OATP-B transport. E 1 S uptake was measured at 1 min in wild-type (f) and OATP-B transfectants (u) in the absence (bars 1, 3, and 5) and presence of PGA 1 1 mol/liter (bars 2, 4, and 6). The membrane permeable thiol reagent, NEM (bars 3 and 4) inhibited substrate binding and/or transport. The effect of PGA 1 (bar 4) was blocked. The hydrophilic thiol reagent, IASD acid, also inhibited transport (bars 5 and 6), but transport was stimulated 2-fold by PGA 1 (bar 6). Data are mean Ϯ SD of triplicate determinations. Table 2 ).
Discussion
OATP-B appears to be one of the most abundant organic anion uptake carriers expressed in the human mammary gland. Generally, OATP family members exhibit broad substrate specificity, encompassing bile salts, sulfate, and glucuronide conjugates of endogenous and exogenous compounds, anionic peptides, and even cations in some cases (16) . OATP-B is peculiar in that its substrate list is restricted, despite its expression in a broad range of tissues (22) . The transport of E 1 S remains the best characterized function for this carrier and may represent its true physiological role in the mammary gland.
At the protein level, the expression of OATP-B in normal mammary tissue was confined to the myoepithelium. Myoepithelial cells have contractile properties required for lactation and can elaborate extracellular matrix proteins, such as collagen and laminin, that are needed to maintain polarity in the adjacent ductal epithelial cells (35) . The current findings identify OATP-B as a steroid sulfate carrier in the myoepithelium. In view of the recent report that marked steroid sulfatase activity is also present in isolated myoepithelial cells (36) , it is tempting to speculate that these cells engage in intercellular cross-talk to supply desulfated hormones to adjacent target cells. OATP-B is also expressed in the epithelia of invasive ductal carcinomas, which are characterized in part by the absence of myoepithelial cells. In these sections, expression was marked in the majority of tumor cells, including those in an active proliferating state. The presence of a steroid sulfate carrier in tumor cells could be a previously unrecognized factor, together with the elevated expression levels of the 17␤-hydroxysteroid dehydrogenase type 1 and aromatase enzymes (12, 37) , that contributes to the high intratumor levels of E 2 reported in some cases. The influence of OATP-B in determining the estrogen level of target cells will, nevertheless, be tempered by the multidrug resistance protein MRP1, the expression of which in epithelial cells of normal and tumoral breast tissue has been documented (34, 38, 39) . MRP1 can export E 1 S (40), and, considering the high variability in expression levels detected in cancer patients (38, 39) , it could have an unpredictable influence on the status and relevance of OATP-B in breast tumors.
Independent of the eventual conversion to E 2 , DHEA itself may exert biological actions on mammary tissue, both on transcription events and through signal transduction mechanisms. There is evidence that DHEA contributes to estrogen receptor-dependent trans-activation of transcription (41, 42) , and DHEA can inhibit vascular smooth muscle cell proliferation through an inhibition of phosphorylation signaling (43) .
Pregnenolone sulfate, an adrenal steroid that serves as a precursor for DHEA and progesterone, achieves circulating concentrations of approximately 1 mol/liter (44) . There is some evidence that the enzymatic pathway from pregnenolone to 17-hydroxypregnenolone to DHEA and androstenedione is intact in human breast tissue (45) and that pregnenolone sulfate can accumulate in fibrocystic breast cyst fluid in concentrations up to 20 times greater than in serum (46) . In light of previous findings that pregnenolone sulfate could inhibit OATP-B-mediated E 1 S uptake in an oocyte expression system and in basal membrane vesicles isolated from placental syncytiotrophoblast (28), we speculated that OATP-B may be a broad-spectrum steroid sulfate carrier and could accept such a relevant steroid hormone precursor. Despite the clearly evident interaction of pregnenolone sulfate with the OATP-B carrier to inhibit E 1 S transport, it is not a substrate. Therefore, OATP-B remains a selective carrier but one that is susceptible to inhibition by other physiological steroids.
The finding that PGA 1 and PGA 2 can stimulate OATP-Bmediated uptake implies that E 1 S and DHEAS cellular entry can be regulated locally at the plasma membrane, possibly with downstream consequences of increased hormone exposure in target cells. PGE 2 is a product of arachidonic acid metabolism and is secreted by breast tumor cells as well as stromal cells (47) (48) (49) . Its formation is catalyzed by cyclooxygenase 2, an enzyme up-regulated in breast cancer tissue. PGA 1 and PGA 2 arise from the dehydration of PGE 1 and PGE 2 , respectively, both intracellularly and in the circulation. It follows that PGA 1 and/or PGA 2 are physiologically relevant and available for interaction with the OATP-B carrier. The mode of this interaction requires detailed study, but the present findings emphasize that the reactive cyclopentenone ring and cysteine residues are critical elements (Fig. 8, B and C). PGA can form adducts with selected proteins: PGA 1 covalently binds to IB kinase to inhibit the phosphorylation of IB␣ (50), and PGA 2 binds covalently to Cys 47 of the glutathione S-transferase P1 isozyme (51) . Therefore, a reaction between PGA 1 /PGA 2 and one or more cysteine residue of OATP-B can be counted as a plausible mechanism but one that must accommodate a resulting increase in activity rather than a decrease. As with the other members of the human OATP superfamily, OATP-B has several Cys residues within the purported extracellular domains (16) . It is likely that one or more are important for substrate binding and transport because E 1 S uptake is sensitive to the thiol reagents, NEM and IASD. PGA 1 remains effective in the presence of the impermeable IASD, suggesting that PGA 1 is acting at a distinct site, inaccessible to the hydrophilic reagent but vulnerable to the more lipophilic PG. The mechanism by which the proposed PGA 1 -OATP-B interaction stimulates transport has not been addressed here. One reasonable hypothesis involves consideration of the quaternary structure of this integral membrane protein. OATP-B has 12 putative membrane-spanning domains, a characteristic it shares with all members of the solute carrier family SLC21A (16) . Other membrane transporters with a similar 12 trans-membrane domain structure, such as glucose transporter type 1 belonging to the SLC2A solute carrier family and the serotonin and dopamine transporters that are members of the SLC6A family, form oligomers mediated by disulfide bonds. A change in the state of oligomerization carries functional consequences (52, 53) . If OATP-B shares these biochemical features, it is possible that PGA could intervene at critical Cys residues to induce a more favorable oligomeric structure. OATP-B was not expressed in three widely used, phenotypically characterized breast cancer cell lines (Table 2 ). This precludes their fortuitous use as model cell lines in which to conduct additional regulatory studies against backgrounds of varying steroid hormone receptor levels and metabolic pathways. The lack of OATP-B notwithstanding, both MCF-7 and T47-D cells respond positively to exposure to E 1 S and DHEAS, with changes in downstream metabolites and growth (4, 54, 55) . The fact that both cell lines express OATP-D and OATP-E to some degree (Table 2) and that E 1 S is listed as a weak substrate for both of these carriers (22) could account for this. Whether OATP-D and OATP-E have a role in determining steroid hormone levels in human breast tissue has yet to be examined.
The perceived risk of estrogen exposure in the genesis and progression of breast cancer is strong. In light of the current findings, additional studies that specifically address 1) the comparative expression of OATP-B in breast tumors and normal tissue and 2) the possible coordinate regulation of this carrier with enzymes that metabolize precursors to downstream, biologically active hormones, are warranted. Moreover, the possibility that the interaction with PG of the A series constitutes a point of regulation for the actions of OATP-B in breast tissue merits further consideration.
